Olmesartan Medoxomil powder is not metabolized by hepatic cytochrome P450 system and has no effect on P450 enzyme. Therefore, product interactions related to inhibition, induction or metabolism of these enzymes will not occur. It is a chemical product for treating hypertension.
FAQ
01.Do you have a problem whit delivery to my country?
02.How to proceed order?
03.When will you sent out the goods after successful payment?
04.What modes of transportation do you have to choose?
05.How is the goods packed?
06.What do you do? What products do you have?
Send your Inquiry for more details, Click email：sales4@faithfulbio.com
Precautions For Product Use
Olmesartan Medoxomil powder is mainly used to treat hypertension. It should be used under the guidance of a doctor. If it is unwell, you should seek medical advice in time, find out the cause and treat it accordingly.
Olmesartan medoxomil is an effective antihypertensive product, which can reduce vascular resistance and blood pressure. It can be used alone or together with other antihypertensive products under the guidance of a doctor. It should be noted that the elderly and children should use olmesartan medoxomil carefully under the guidance of doctors, while pregnant women and patients with asthma should not use olmesartan medoxomil.
If Olmesartan Medoxomil powder is used for a long time, some people may have adverse reactions, such as increased blood potassium level, leading to muscle paralysis, diarrhea, headache, nausea, vomiting and other adverse reactions. Therefore, during the use of olmesartan medoxomil, we should pay attention to check the blood potassium level, change the dosage according to the doctor's advice or switch to other products.
During the use of Olmesartan Medoxomil powder, we should avoid eating irritating food. At the same time, we must ensure adequate rest, which is conducive to physical recovery.
Product News
The FDA warned that olmesartan medoxomil may cause intestinal problems, so-called aphthous enteropathy. The FDA has approved changing the labels of these products to include this issue. Symptoms of aphthous enteropathy include severe chronic diarrhea and obvious weight loss. Intestinal diseases may occur several months to several years after starting olmesartan treatment, and sometimes hospitalization is needed. If these symptoms appear and no other reasons are found, you should stop using them and start using another antihypertensive product for treatment. After stopping olmesartan, the symptoms of diarrhea-like bowel disease in all patients were improved clinically.
Olmesartan Medoxomil powder is an angiotensin II receptor blocker (ARB), which is approved for the treatment of hypertension alone or together with other antihypertensive products, and is one of the eight ARBs listed on the market. Except olmesartan, other ARBs did not detect aphthous enteropathy.
Send your Inquiry for more details, Click email：sales4@faithfulbio.com